Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor.

Sutton, Thomas L; Walker, Brett S; Billingsley, Kevin G; Sheppard, Brett C; Corless, Christopher L; Heinrich, Michael C; Mayo, Skye C

Sutton, Thomas L; Walker, Brett S; Billingsley, Kevin G; Sheppard, Brett C; Corless, Christopher L; Heinrich, Michael C; Mayo, Skye C.

Afiliação

Sutton TL; Department of Surgery, Oregon Health and Science University, Portland, OR, USA.
Walker BS; Department of Surgery, Oregon Health and Science University, Portland, OR, USA.
Billingsley KG; Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Sheppard BC; Department of Surgery, Oregon Health and Science University, Portland, OR, USA.
Corless CL; Department of Pathology, Oregon Health and Science University, Portland, OR, USA.
Heinrich MC; Portland VA Health Care System, Portland, OR, USA.
Mayo SC; Division of Surgical Oncology, The Knight Cancer Institute at Oregon Health and Science University, Portland, OR, USA.

Ann Surg Oncol ; 28(12): 7912-7920, 2021 Nov.

Article em En | MEDLINE | ID: mdl-33969462

Assuntos

Neoplasias Gastrointestinais; Tumores do Estroma Gastrointestinal; Metastasectomia; Intervalo Livre de Doença; Neoplasias Gastrointestinais/cirurgia; Tumores do Estroma Gastrointestinal/cirurgia; Humanos; Mesilato de Imatinib/uso terapêutico; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Prognóstico; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Metastasectomia / Neoplasias Gastrointestinais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google